• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过宏基因组学和宏转录组学分析下呼吸道微生物群的改变及其与COVID-19严重程度的关联。

Altered microbiota of the lower respiratory tract and its association with COVID-19 severity analysed by metagenomics and metatranscriptomics.

作者信息

Wang Denian, Duan Yishang, He Lijuan, Jiang Juan, Xian Jinghong, Yuan Ke, Zhang Rui, Zhang Huohuo, Wang Jing, Li Nan, Huang Min, Hu Chenggong, Lu Sifeng, Luo Zhiheng, Deng Taibing, Zhang Zhongwei, Chen Bojiang, Li Weimin

机构信息

Precision Medicine Research Center, Precision Medicine Key Laboratory of Sichuan Province, State Key Laboratory of Respiratory Health and Multimorbidity, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Department of Respiratory and Critical Care Medicine, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

出版信息

Commun Biol. 2025 May 26;8(1):804. doi: 10.1038/s42003-025-08234-1.

DOI:10.1038/s42003-025-08234-1
PMID:40419790
Abstract

The interaction between gut and oropharyngeal microbiota plays a significant role in the viral infections like SARS-CoV-2, but role of the lower respiratory tract microbiota remains unclear. Our study utilized metatranscriptomics and metagenomics to analyze the microbial composition of bronchoalveolar lavage fluid and sputum samples from 116 COVID-19 patients, categorized into mild, severe, and critical groups. Our analysis revealed significant differences in viral genotypes across disease stages. As disease severity increased, the Chao index also rose. The mild group was predominantly dominated by Firmicutes, while the severe group showed an increase in Bacteroidetes. The critical group was characterized by a higher abundance of Actinobacteria and Proteobacteria. Notably, the abundance of Streptococcus and Rothia decreased as the disease progressed. Additionally, the Shannon index correlated with mortality risk, while the Chao index was associated with ICU admission, mechanical ventilation, and patient survival. These findings highlight the strong link between microbial composition and COVID-19 severity, providing valuable insights for assessing disease progression.

摘要

肠道微生物群与口咽微生物群之间的相互作用在诸如SARS-CoV-2等病毒感染中起着重要作用,但下呼吸道微生物群的作用仍不清楚。我们的研究利用宏转录组学和宏基因组学分析了116例COVID-19患者的支气管肺泡灌洗液和痰液样本的微生物组成,这些患者被分为轻症、重症和危重症组。我们的分析揭示了不同疾病阶段病毒基因型的显著差异。随着疾病严重程度的增加,Chao指数也上升。轻症组主要以厚壁菌门为主,而重症组拟杆菌门增加。危重症组的特征是放线菌门和变形菌门的丰度较高。值得注意的是,随着疾病进展,链球菌属和罗氏菌属的丰度下降。此外,香农指数与死亡风险相关,而Chao指数与入住重症监护病房、机械通气和患者生存相关。这些发现突出了微生物组成与COVID-19严重程度之间的紧密联系,为评估疾病进展提供了有价值的见解。

相似文献

1
Altered microbiota of the lower respiratory tract and its association with COVID-19 severity analysed by metagenomics and metatranscriptomics.通过宏基因组学和宏转录组学分析下呼吸道微生物群的改变及其与COVID-19严重程度的关联。
Commun Biol. 2025 May 26;8(1):804. doi: 10.1038/s42003-025-08234-1.
2
Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome.机械通气 COVID-19 患者下呼吸道中的微生物特征与不良临床结局相关。
Nat Microbiol. 2021 Oct;6(10):1245-1258. doi: 10.1038/s41564-021-00961-5. Epub 2021 Aug 31.
3
Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients.对确诊和疑似 COVID-19 患者的鼻咽拭子标本进行宏基因组下一代测序。
mBio. 2020 Nov 20;11(6):e01969-20. doi: 10.1128/mBio.01969-20.
4
Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes.COVID-19 患者中严重和致命结局与呼吸微生物群失调和结构破坏。
Sci Rep. 2021 Oct 29;11(1):21297. doi: 10.1038/s41598-021-00851-0.
5
Metagenomic next-generation sequencing of nasopharyngeal microbiota in COVID-19 patients with different disease severities.对不同疾病严重程度的 COVID-19 患者鼻咽微生物群的宏基因组下一代测序。
Microbiol Spectr. 2024 May 2;12(5):e0416623. doi: 10.1128/spectrum.04166-23. Epub 2024 Apr 1.
6
Assessment of upper respiratory and gut bacterial microbiomes during COVID-19 infection in adults: potential aerodigestive transmission.成人新冠病毒感染期间上呼吸道和肠道细菌微生物群评估:气消化道传播的可能性
Sci Rep. 2025 Jan 13;15(1):1811. doi: 10.1038/s41598-025-85806-5.
7
Upper and lower respiratory tract microbiota in horses: bacterial communities associated with health and mild asthma (inflammatory airway disease) and effects of dexamethasone.马的上、下呼吸道微生物群:与健康和轻度哮喘(炎性气道疾病)相关的细菌群落以及地塞米松的影响
BMC Microbiol. 2017 Aug 23;17(1):184. doi: 10.1186/s12866-017-1092-5.
8
Deciphering the lung microbiota in COVID-19 patients: insights from culture analysis, FilmArray pneumonia panel, ventilation impact, and mortality trends.解析新冠病毒肺炎患者的肺部微生物群:来自培养分析、FilmArray肺炎检测板、通气影响及死亡率趋势的见解
Sci Rep. 2024 Dec 3;14(1):30035. doi: 10.1038/s41598-024-81738-8.
9
Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients.早期高病毒载量诱导干扰素反应可能有助于预防 COVID-19 患者的重症结局。
Sci Rep. 2021 Aug 3;11(1):15715. doi: 10.1038/s41598-021-95197-y.
10
Unravelling distinct patterns of metagenomic surveillance and respiratory microbiota between two P1 genotypes of .揭示两种P1基因型之间宏基因组监测和呼吸道微生物群的不同模式。 (注:原文句末不完整,推测补充完整后可能是这样的翻译)
Emerg Microbes Infect. 2025 Dec;14(1):2449087. doi: 10.1080/22221751.2024.2449087. Epub 2025 Jan 13.

引用本文的文献

1
Respiratory microbiota, host immunity, respiratory viral infections and malignant tumors.呼吸道微生物群、宿主免疫、呼吸道病毒感染与恶性肿瘤。
Front Microbiol. 2025 Jul 10;16:1626077. doi: 10.3389/fmicb.2025.1626077. eCollection 2025.
2
Tracing the evolutionary pathway of SARS-CoV-2 through RNA sequencing analysis.通过RNA测序分析追踪新冠病毒的进化路径。
Sci Rep. 2025 Jul 4;15(1):23961. doi: 10.1038/s41598-025-09911-1.

本文引用的文献

1
Association Between Candida albicans and COVID-19 in Complete Denture Wearers: An Observational Study.全口义齿佩戴者白色念珠菌与新型冠状病毒肺炎的关联:一项观察性研究。
Cureus. 2023 Oct 27;15(10):e47777. doi: 10.7759/cureus.47777. eCollection 2023 Oct.
2
Metatranscriptome of human lung microbial communities in a cohort of mechanically ventilated COVID-19 Omicron patients.机械通气的 COVID-19 奥密克戎患者队列中人类肺部微生物群落的宏转录组。
Signal Transduct Target Ther. 2023 Nov 10;8(1):432. doi: 10.1038/s41392-023-01684-1.
3
Comparison of respiratory pathogens in children with community-acquired pneumonia before and during the COVID-19 pandemic.
比较 COVID-19 大流行前后儿童社区获得性肺炎的呼吸道病原体。
BMC Pediatr. 2023 Oct 27;23(1):535. doi: 10.1186/s12887-023-04246-0.
4
Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19.真菌微生物群在严重 COVID-19 中维持中性粒细胞及其前体细胞的持久免疫激活。
Nat Immunol. 2023 Nov;24(11):1879-1889. doi: 10.1038/s41590-023-01637-4. Epub 2023 Oct 23.
5
Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota.饮食调节的肠道微生物群对 SARS-CoV-2 感染的调控。
Front Cell Infect Microbiol. 2023 Jun 29;13:1167827. doi: 10.3389/fcimb.2023.1167827. eCollection 2023.
6
The COVID-19 pandemic as an opportunity for unravelling the causative association between respiratory viruses and pneumococcus-associated disease in young children: a prospective study.COVID-19 大流行提供了一个机会,可以揭示呼吸道病毒与小儿肺炎球菌相关疾病之间的因果关联:一项前瞻性研究。
EBioMedicine. 2023 Apr;90:104493. doi: 10.1016/j.ebiom.2023.104493. Epub 2023 Feb 28.
7
Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: A systematic review.新冠疫情对耐多药革兰阳性和革兰阴性病原体的影响:系统综述。
J Infect Public Health. 2023 Mar;16(3):320-331. doi: 10.1016/j.jiph.2022.12.022. Epub 2022 Dec 31.
8
Comparison of the respiratory tract microbiome in hospitalized COVID-19 patients with different disease severity.比较不同疾病严重程度的住院 COVID-19 患者的呼吸道微生物组。
J Med Virol. 2022 Nov;94(11):5284-5293. doi: 10.1002/jmv.28002. Epub 2022 Jul 26.
9
Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.新冠病毒感染期间,继发性细菌性感染的易感性和严重程度呈时间依赖性增加。
Front Immunol. 2022 May 12;13:894534. doi: 10.3389/fimmu.2022.894534. eCollection 2022.
10
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions.COVID-19 患者的微生物组变化:潜在机制和治疗干预措施。
Signal Transduct Target Ther. 2022 Apr 29;7(1):143. doi: 10.1038/s41392-022-00986-0.